Management of patients at high risk of developing skin melanoma: organizational and clinical aspects-Reference-Cited by-同舟云学术

Management of patients at high risk of developing skin melanoma: organizational and clinical aspects

Published:2021-06-07 Issue:8 Volume: Page:21-26
ISSN:2658-5790
Container-title:Meditsinskiy sovet = Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Michenko A. V.¹^ORCID,Zhukova O. V.²^ORCID,Ostretsova M. N.³^ORCID,Novozhilova O. L.¹^ORCID

Affiliation:

1. Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

2. Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Peoples’ Friendship University of Russia

3. Peoples’ Friendship University of Russia

Abstract

Early diagnosis of skin melanoma is one of the most reliable ways to improve the prognosis for the life of patients with this tumor. Organization of medical care for patients with a high risk of developing melanoma, together with the use of non-invasive diagnostic methods and teaching the patient the principles of prevention and early diagnosis of skin malignancies should improve the survival rates of patients with melanoma. The article discusses the experience of implementing the Organizational model of medical care for patients with skin neoplasms in Moscow, as well as the key rules for managing patients at risk of developing skin melanoma with special emphasis on recommendations to patients for regular self-examination of the skin, lifestyle correction and the use of photoprotective agents.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference17 articles.

1. Kaprin A.D., Starinskiy V.V., Petrova G.V. (eds.). Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow: P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 2019. 250 p. (In Russ.) Available at: https://oncology-association.ru/wpcontent/uploads/2020/09/2018.pdf.

2. Elwood J.M., Gallagher R.P., Worth A.J., Wood W.S., Pearson J.C. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst. 1987;78(1):37–44. doi: 10.1093/jnci/78.1.37.

3. Warner A.B., Postow M.A. Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma? Oncology (Williston Park). 2018;32(5):228–234. Available at: https://pubmed.ncbi.nlm.nih.gov/29847853.

4. Green A.C., Baade P., Coory M., Aitken J.F., Smithers M. Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia. J Clin Oncol. 2012;30(13):1462–1467. doi: 10.1200/jco.2011.38.8561.

5. Potekaev N.N., Zhukova O.V., Novozhilova O.L., Mel’nichenko O.O., Kochetkov M.A., Michenko A.V. et al. Experience of the Moscow Center of Dermatovenerology and Cosmetology of the Moscow Department of Healt in the creation and implementation of the program ‘Early diagnosis and prevention of skin melanoma in Moscow’. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2020;19(1): 53–63. (In Russ.) doi: 10.17116/klinderma20201901153.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DIAGNOSIS OF MELANOMA: CURRENT STATE AND PROSPECTS (literature review);Clinical Medicine and Pharmacology;2023-12-26

2. DIAGNOSIS OF SKIN MELANOMA: CURRENT STATUS AND PROSPECTS (literature review);Clinical Medicine and Pharmacology;2023-05-15

3. SURGICAL ASPECTS TREATMENT OF SKIN MELANOMA (literature review);Clinical Medicine and Pharmacology;2023-05-15